182 related articles for article (PubMed ID: 35924298)
1. Synthesis and evaluation of carbamate derivatives as fatty acid amide hydrolase and monoacylglycerol lipase inhibitors.
Jaiswal S; Gupta G; Ayyannan SR
Arch Pharm (Weinheim); 2022 Nov; 355(11):e2200081. PubMed ID: 35924298
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of dual fatty acid amide hydrolase-monoacylglycerol lipase inhibition and antinociceptive activities of 4-methylsulfonylaniline-derived semicarbazones.
Jaiswal S; Akhilesh ; Uniyal A; Tiwari V; Raja Ayyannan S
Bioorg Med Chem; 2022 Apr; 60():116698. PubMed ID: 35296453
[TBL] [Abstract][Full Text] [Related]
3. Piperazine and piperidine carboxamides and carbamates as inhibitors of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL).
Korhonen J; Kuusisto A; van Bruchem J; Patel JZ; Laitinen T; Navia-Paldanius D; Laitinen JT; Savinainen JR; Parkkari T; Nevalainen TJ
Bioorg Med Chem; 2014 Dec; 22(23):6694-6705. PubMed ID: 25282655
[TBL] [Abstract][Full Text] [Related]
4. Hexafluoroisopropyl Carbamates as Selective MAGL and Dual MAGL/FAAH Inhibitors: Biochemical and Physicochemical Properties.
Barth M; Rudolph S; Kampschulze J; Meyer Zu Vilsendorf I; Hanekamp W; Mulac D; Langer K; Lehr M
ChemMedChem; 2022 May; 17(9):e202100757. PubMed ID: 35072346
[TBL] [Abstract][Full Text] [Related]
5. Discovery of Isatin-Based Carbohydrazones as Potential Dual Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase.
Jaiswal S; Ayyannan SR
ChemMedChem; 2022 Jan; 17(1):e202100559. PubMed ID: 34637598
[TBL] [Abstract][Full Text] [Related]
6. (4-Phenoxyphenyl)tetrazolecarboxamides and related compounds as dual inhibitors of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL).
Holtfrerich A; Hanekamp W; Lehr M
Eur J Med Chem; 2013 May; 63():64-75. PubMed ID: 23455058
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB
Owens RA; Mustafa MA; Ignatowska-Jankowska BM; Damaj MI; Beardsley PM; Wiley JL; Niphakis MJ; Cravatt BF; Lichtman AH
Neuropharmacology; 2017 Oct; 125():80-86. PubMed ID: 28673548
[TBL] [Abstract][Full Text] [Related]
8. A comparison of novel, selective fatty acid amide hydrolase (FAAH), monoacyglycerol lipase (MAGL) or dual FAAH/MAGL inhibitors to suppress acute and anticipatory nausea in rat models.
Parker LA; Limebeer CL; Rock EM; Sticht MA; Ward J; Turvey G; Benchama O; Rajarshi G; Wood JT; Alapafuja SO; Makriyannis A
Psychopharmacology (Berl); 2016 Jun; 233(12):2265-75. PubMed ID: 27048155
[TBL] [Abstract][Full Text] [Related]
9. New Disulfiram Derivatives as MAGL-Selective Inhibitors.
Omran Z
Molecules; 2021 May; 26(11):. PubMed ID: 34070869
[TBL] [Abstract][Full Text] [Related]
10. Potent dual MAGL/FAAH inhibitor AKU-005 engages endocannabinoids to diminish meningeal nociception implicated in migraine pain.
Della Pietra A; Krivoshein G; Ivanov K; Giniatullina R; Jyrkkänen HK; Leinonen V; Lehtonen M; van den Maagdenberg AMJM; Savinainen J; Giniatullin R
J Headache Pain; 2023 Apr; 24(1):38. PubMed ID: 37038131
[TBL] [Abstract][Full Text] [Related]
11. O-hydroxyacetamide carbamates as a highly potent and selective class of endocannabinoid hydrolase inhibitors.
Niphakis MJ; Johnson DS; Ballard TE; Stiff C; Cravatt BF
ACS Chem Neurosci; 2012 May; 3(5):418-26. PubMed ID: 22860211
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and in vitro evaluation of carbamate derivatives of 2-benzoxazolyl- and 2-benzothiazolyl-(3-hydroxyphenyl)-methanones as novel fatty acid amide hydrolase inhibitors.
Myllymäki MJ; Saario SM; Kataja AO; Castillo-Melendez JA; Nevalainen T; Juvonen RO; Järvinen T; Koskinen AM
J Med Chem; 2007 Aug; 50(17):4236-42. PubMed ID: 17665899
[TBL] [Abstract][Full Text] [Related]
13. Development and characterization of endocannabinoid hydrolases FAAH and MAGL inhibitors bearing a benzotriazol-1-yl carboxamide scaffold.
Morera L; Labar G; Ortar G; Lambert DM
Bioorg Med Chem; 2012 Nov; 20(21):6260-75. PubMed ID: 23036333
[TBL] [Abstract][Full Text] [Related]
14. Anticancer Potential of Small-Molecule Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase.
Jaiswal S; Ayyannan SR
ChemMedChem; 2021 Jul; 16(14):2172-2187. PubMed ID: 33834617
[TBL] [Abstract][Full Text] [Related]
15. Discriminative Stimulus Properties of the Endocannabinoid Catabolic Enzyme Inhibitor SA-57 in Mice.
Owens RA; Ignatowska-Jankowska B; Mustafa M; Beardsley PM; Wiley JL; Jali A; Selley DE; Niphakis MJ; Cravatt BF; Lichtman AH
J Pharmacol Exp Ther; 2016 Aug; 358(2):306-14. PubMed ID: 27307500
[TBL] [Abstract][Full Text] [Related]
16. Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo.
Long JZ; Nomura DK; Vann RE; Walentiny DM; Booker L; Jin X; Burston JJ; Sim-Selley LJ; Lichtman AH; Wiley JL; Cravatt BF
Proc Natl Acad Sci U S A; 2009 Dec; 106(48):20270-5. PubMed ID: 19918051
[TBL] [Abstract][Full Text] [Related]
17. Overview of the chemical families of fatty acid amide hydrolase and monoacylglycerol lipase inhibitors.
Vandevoorde S
Curr Top Med Chem; 2008; 8(3):247-67. PubMed ID: 18289091
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of 2-acylglycerol in rabbit and human platelets. Involvement of monoacylglycerol lipase and fatty acid amide hydrolase.
Gkini E; Anagnostopoulos D; Mavri-Vavayianni M; Siafaka-Kapadai A
Platelets; 2009 Sep; 20(6):376-85. PubMed ID: 19811221
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of monoacylglycerol lipase and fatty acid amide hydrolase by analogues of 2-arachidonoylglycerol.
Ghafouri N; Tiger G; Razdan RK; Mahadevan A; Pertwee RG; Martin BR; Fowler CJ
Br J Pharmacol; 2004 Nov; 143(6):774-84. PubMed ID: 15492019
[TBL] [Abstract][Full Text] [Related]
20. 1,3,4-Oxadiazol-2-ones as fatty-acid amide hydrolase and monoacylglycerol lipase inhibitors: Synthesis, in vitro evaluation and insight into potency and selectivity determinants by molecular modelling.
Käsnänen H; Minkkilä A; Taupila S; Patel JZ; Parkkari T; Lahtela-Kakkonen M; Saario SM; Nevalainen T; Poso A
Eur J Pharm Sci; 2013 Jun; 49(3):423-33. PubMed ID: 23557840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
